Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.91% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -3.43% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -18.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -9.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.02% |
| Dec 31, 2025 | -27.25% |
| Sep 30, 2025 | 1.57% |
| Jun 30, 2025 | -4.29% |
| Mar 31, 2025 | -7.70% |
| Dec 31, 2024 | -15.36% |
| Sep 30, 2024 | 2.06% |
| Jun 30, 2024 | 7.16% |
| Mar 31, 2024 | 4.29% |
| Dec 31, 2023 | -19.29% |
| Sep 30, 2023 | 11.83% |
| Jun 30, 2023 | 31.82% |
| Mar 31, 2023 | 16.94% |
| Dec 31, 2022 | 27.98% |
| Sep 30, 2022 | 9.57% |
| Jun 30, 2022 | -6.62% |
| Mar 31, 2022 | -3.39% |
| Dec 31, 2021 | 5.65% |
| Sep 30, 2021 | 4.50% |
| Jun 30, 2021 | -1.64% |
| Mar 31, 2021 | 33.96% |
| Dec 31, 2020 | 10.07% |
| Sep 30, 2020 | 7.63% |
| Jun 30, 2020 | -98.73% |
| Mar 31, 2020 | -16.50% |
| Dec 31, 2019 | 16.54% |
| Sep 30, 2019 | -16.32% |
| Jun 30, 2019 | 12.27% |
| Mar 31, 2019 | 3.10% |
| Dec 31, 2018 | 10.85% |
| Sep 30, 2018 | -48.37% |
| Jun 30, 2018 | -15.93% |
| Mar 31, 2018 | -45.67% |
| Dec 31, 2017 | 4.35% |
| Sep 30, 2017 | -11.93% |
| Jun 30, 2017 | -10.75% |
| Mar 31, 2017 | -1.40% |
| Dec 31, 2016 | -43.70% |
| Sep 30, 2016 | 38.55% |
| Jun 30, 2016 | -10.64% |
| Mar 31, 2016 | -1.45% |
| Dec 31, 2015 | 4.09% |
| Sep 30, 2015 | 103.84% |